Difference between revisions of "Chiolero 2023 Eur J Epidemiol"
(Created page with "{{Publication |title=Chiolero A, Tancredi S, Ioannidis JPA (2023) Slow data public health. Eur J Epidemiol https://doi.org/10.1007/s10654-023-01049-6 |info=[https://pubmed.ncb...") Β |
|||
Line 10: | Line 10: | ||
{{Labeling | {{Labeling | ||
|area=Pharmacology;toxicology | |area=Pharmacology;toxicology | ||
|additional=Gentle Science | |additional=Gentle Science, Publication efficiency | ||
}} | }} |
Revision as of 01:00, 28 November 2023
Chiolero A, Tancredi S, Ioannidis JPA (2023) Slow data public health. Eur J Epidemiol https://doi.org/10.1007/s10654-023-01049-6 |
Chiolero A, Tancredi S, Ioannidis JPA (2023) Eur J Epidemiol
Abstract: Surveillance and research data, despite their massive production, often fail to inform evidence-based and rigorous data-driven health decision-making. In the age of infodemic, as revealed by the COVID-19 pandemic, providing useful information for decision-making requires more than getting more data. Data of dubious quality and reliability waste resources and create data-genic public health damages. We call therefore for a slow data public health, which means focusing, first, on the identification of specific information needs and, second, on the dissemination of information in a way that informs decision-making, rather than devoting massive resources to data collection and analysis. A slow data public health prioritizes better data, ideally population-based, over more data and aims to be timely rather than deceptively fast. Applied by independent institutions with expertise in epidemiology and surveillance methods, it allows a thoughtful and timely public health response, based on high-quality data fostering trustworthiness.
β’ Bioblast editor: Gnaiger E
Labels: MiParea: Pharmacology;toxicology
Gentle Science, Publication efficiency